47
Participants
Start Date
August 31, 2004
Primary Completion Date
February 29, 2012
Study Completion Date
October 31, 2013
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu -J591)
"Eligible patients will receive a single dose of 177Lu-J591 (65 or 70 mCi/m2) consisting of J591 chelated at a specific activity of 12-15 mCi of 177Lu per mg of antibody plus sufficient non-radiolabeled, non-DOTA-conjugated (naked) J591 to achieve a total antibody dose of 20 mg. Each dose will be administered by an IV infusion at a rate not to exceed 5 mg/min."
Weill Medcial College of Cornell University, New York
Weill Medical College of Cornell University
OTHER